2011 - Transplantomics and Biomarkers in Transplantation


Biomarkers to Improve Patient Management in Solid Organ Transplantation

2.2 - Personalizing Medicine in Organ Transplantation

Presenter: Maarten, Naesens­­, Leuven, Belgium
Authors: Maarten Naesens


Personalizing Medicine in Organ Transplantation

Maarten Naesens­­, University Hospitals Leuven, Leuven, Belgium

The talk will review the importance of personalized medicine in organ transplantation and will highlight how to follow a generalized process in biomarker discovery for personalized medicine: collecting and storing samples for data analysis; compiling and understanding the mass of data from samples; and translating the research findings into clinical practice. The problems with the age-old strategies in diagnosing allograft dysfunction has led to the use of the genome, proteome and metabolome, in concert with clinical data, for –omics approaches in predicting and diagnosing disease.

New molecular and biomarker discovery efforts for transplant injury in relation to the graft, peripheral blood and urine can begin to highlight the ongoing importance of pathology as an important means to stratify treatment choices for different mechanisms of transplant injury. The challenge is now to apply these fantastic advances in technology to clinical applications.


You must be logged in to view recordings

Important Disclaimer

By viewing the material on this site you understand and accept that:

  1. The opinions and statements expressed on this site reflect the views of the author or authors and do not necessarily reflect those of The Transplantation Society and/or its Sections.
  2. The hosting of material on The Transplantation Society site does not signify endorsement of this material by The Transplantation Society and/or its Sections.
  3. The material is solely for educational purposes for qualified health care professionals.
  4. The Transplantation Society and/or its Sections are not liable for any decision made or action taken based on the information contained in the material on this site.
  5. The information cannot be used as a substitute for professional care.
  6. The information does not represent a standard of care.
  7. No physician-patient relationship is being established.

Our Corporate Sponsors

TTS gratefully acknowledges the Corporate Partners whose generous support makes the work of the Society possible:

  • astellas
  • roche
  • sanofi